SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | CORRESP |
CORRESP |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | CORRESP |
CORRESP |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | CORRESP |
CORRESP |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | CORRESP |
CORRESP |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | CT ORDER |
CT ORDER |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Definitive proxy statement relating to merger or acquisition |
DEFM14A |
Mergers & Acquisitions
|
Eidos Therapeutics, Inc. | |
| View HTML | Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |
Registration Statements
|
Eidos Therapeutics, Inc. | |
| View HTML | EFFECT |
EFFECT |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | EFFECT |
EFFECT |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | EFFECT |
EFFECT |
Other
|
Eidos Therapeutics, Inc. |
Displaying 31 - 40 of 238 results
Data provided by Kaleidoscope.